المؤلفون: Takshay Gandhi, Paras Acharya, Pathik Vala, Rutvik Shah, Rahul Bhatt

المصدر: International Journal of Orthopaedics Sciences. 5:739-743

مصطلحات موضوعية: medicine.medical_specialty, Rehabilitation, Full weight bearing, business.industry, medicine.medical_treatment, Bipolar hemiarthroplasty, Tertiary care, Surgery, Harris Hip Score, Inclusion and exclusion criteria, medicine, Femur, Prospective cohort study, business

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::76be8a6cbf99780b61d8c2f1fe3483bf
https://doi.org/10.22271/ortho.2019.v5.i2k.81

المؤلفون: Bed Khadka, Abhinaya Pathak, Jennifer Wilson, Prashamsa Paudel, Paras Acharya, Ashok Ram, Lokendra Adhikari

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::397693468ace965429ee7a9658aa5233
https://doi.org/10.22541/au.162078157.76181753/v1

المؤلفون: Nora Ranjitkar Manandhar, Paras Acharya, Gyan Kayastha

المصدر: Journal of Patan Academy of Health Sciences. 5:47-56

مصطلحات موضوعية: Oncology, medicine.medical_specialty, business.industry, medicine.drug_class, Third-line therapy, Myeloid leukemia, Imatinib, Tyrosine-kinase inhibitor, Dasatinib, Nilotinib, hemic and lymphatic diseases, Internal medicine, Major Molecular Response, Medicine, business, Complete Hematologic Response, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::bccef478bce279bacfae763a09295142
https://doi.org/10.3126/jpahs.v5i1.24042

المؤلفون: Roshan Shrestha, David J. Roberts, Buddhi Poudyal, Raj Kumar Kc, Gyan Kayastha, Paras Acharya, Buddha Basnyat, Radha Gurung, Sanjit Karki, Bruce Hayes, Nora Ranjitkar, Raj Kumar Thapa, Mark Zimmerman, Piyush Rajbhandari

المصدر: British Journal of Haematology. 177(6)

مصطلحات موضوعية: Male, 0301 basic medicine, Oncology, medicine.medical_specialty, Fusion Proteins, bcr-abl, Antineoplastic Agents, Philadelphia chromosome, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Internal medicine, hemic and lymphatic diseases, Humans, Medicine, Retrospective Studies, ABL, business.industry, Ponatinib, breakpoint cluster region, Imatinib, Hematology, Protein-Tyrosine Kinases, medicine.disease, Dasatinib, 030104 developmental biology, Nilotinib, chemistry, Drug Resistance, Neoplasm, 030220 oncology & carcinogenesis, Mutation, Imatinib Mesylate, Female, business, Tyrosine kinase, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::322c734886a67451396f0d02cae3cd97
http://ora.ox.ac.uk/objects/uuid:

المؤلفون: Piyush Rajbhandari, Buddha Basnyat, David J. Roberts, Paras Acharya, Raj Kumar Kc, Nora Ranjitkar, Raj Kumar Thapa, Buddhi Poudyal, Radha Gurung, Aaron S. Mansfield, Gyan Kayastha, Roshan R. Shrestha, Sanjit Karki, Bruce Hayes, Mark Zimmerman

المصدر: British Journal of Haematology. 177(6)

مصطلحات موضوعية: Adult, 0301 basic medicine, medicine.medical_specialty, Adolescent, Medically Underserved Area, Antineoplastic Agents, Kaplan-Meier Estimate, Philadelphia chromosome, Young Adult, 03 medical and health sciences, Bcr abl1, 0302 clinical medicine, Nepal, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Internal medicine, hemic and lymphatic diseases, medicine, Humans, Young adult, Child, Aged, Aged, 80 and over, ABL, Reverse Transcriptase Polymerase Chain Reaction, business.industry, breakpoint cluster region, Imatinib, Hematology, Middle Aged, medicine.disease, Surgery, Treatment Outcome, 030104 developmental biology, Imatinib mesylate, 030220 oncology & carcinogenesis, Cohort, Imatinib Mesylate, business, Follow-Up Studies, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9a57c20ce4bc41913bc0bcea75f7d669
http://ora.ox.ac.uk/objects/uuid:

المؤلفون: Padma Gurung, Mark Zimmerman, Gyan Kayastha, Bruce Hayes, B P Paudyal, A Karki, Paras Acharya, Aaron S. Mansfield

المصدر: BMC Blood Disorders
BMC Blood Disorders, Vol 10, Iss 1, p 8 (2010)

مصطلحات موضوعية: medicine.drug_class, business.industry, lcsh:RC633-647.5, Myeloid leukemia, Imatinib, Hematology, lcsh:Diseases of the blood and blood-forming organs, Pharmacology, Philadelphia chromosome, medicine.disease, Tyrosine-kinase inhibitor, Dasatinib, Imatinib mesylate, Nilotinib, hemic and lymphatic diseases, medicine, Cancer research, business, Molecular Biology, Tyrosine kinase, neoplasms, medicine.drug, Research Article

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::860ef9ac05d6e7d63c7d5c41a224f30a
https://pubmed.ncbi.nlm.nih.gov/21138592